Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sleep Apnea, Obstructive 1 Polycystic Ovary Syndrome 1 Metabolic Syndrome 1 Insulin Resistance 1 Glucose Intolerance 1 Breast Neoplasms 1

Interventions

Letrozole 20 Docetaxel 16 Cyclophosphamide 13 Zoledronic Acid 12 exemestane 11 Trastuzumab 11 Anastrozole 11 Paclitaxel 10 Tamoxifen 9 Capecitabine 9 Fulvestrant 8 Epirubicin 8 pegfilgrastim 7 pertuzumab 6 liposomal doxorubicin 6 abemaciclib 6 Saline Solution 6 palbociclib 5 Sodium Chloride 5 Dexmedetomidine 5 Carboplatin 5 Bupivacaine 5 Bevacizumab 5 ribociclib 4 pegylated granulocyte colony-stimulating factor 4 eribulin 4 Tranexamic Acid 4 Standard of Care 4 Pamidronate 4 Filgrastim 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Breast Neoplasms × Estrogens × Clear all

NCT05562518 2026-04-30

GRACE

University Hospital, Ghent

Phase 4 Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡